- $302.10m
- $333.15m
- $103.12m
Sanara MedTech Q2 revenue rises on soft-tissue product growth
Sanara Medtech Inc expected to post a loss of 2 cents a share - Earnings Preview
NASDAQ RESUMED AT 07:50 PM
Brief: Mimedx To Acquire Sanara Medtech
NASDAQ TRADE HALT HALT NEWS PENDING AT 02:21 PM
Brief: Sanara Medtech Terminates Services Agreement With Catalyst Effective June 2
Sanara MedTech Q1 revenue rises, swings to profit
Sanara MedTech posts higher Q4 revenue, reaffirms guidance
Brief: Sanara MedTech Reports Unaudited Preliminary Financial Results For The Fourth Quarter And Full Year 2025 Introduces Full Year 2026 Financial Guidance
Brief: Sanara Medtech Receives Innovative Technology Contract From Vizient For BIASURGE Advanced Surgical Solution
Medical tech firm Sanara's Q3 revenue misses estimates after Tissue Health Plus unit closure
Brief: Sanara MedTech Announces Chief Executive Officer Transition
Sanara Medtech Inc reports results for the quarter ended June 30 - Earnings Summary
Sanara MedTech Q2 revenue up 28%
Sanara Medtech Inc expected to post a loss of 44 cents a share - Earnings Preview
Sanara Medtech Inc reports results for the quarter ended March 31 - Earnings Summary
Sanara Medtech Inc expected to post a loss of 50 cents a share - Earnings Preview
Sanara Medtech Inc reports results for the quarter ended December 31 - Earnings Summary
Sanara Medtech Inc expected to post a loss of 11 cents a share - Earnings Preview